Dialysis Products

Rockwell Medical is an innovative leader in producing and delivering hemodialysis concentrates (solutions and powders) along with related ancillary products to dialysis providers located throughout the U.S. and abroad. Learn more 

Clinical Program

The company’s lead bio-pharmaceutical iron drug Triferic has completed Phase III clinical trials and is designed to prevent and treat iron deficiency anemia in ESRD patients.
Learn more 

Kidney Disease

Diseases of the kidney are a major health concern in the United States, affecting more than 23 million Americans and causing more than 90,000 deaths annually. Learn more 

Investor Center
Rockwell Medical's common shares are traded on NASDAQ under the symbol RMTI. More ››

About Us

Rockwell is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. As an established manufacturer and leader in delivering high-quality hemodialysis concentrates to dialysis providers and distributors in the U.S. and abroad, Rockwell provides products used to maintain human life, removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. More »